Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Schering-Plough buys China partners
Although the company is staying tight-lipped on the details of the deals, here's a mouthful: Schering-Plough announced yesterday that it purchased Shanghai Pharmaceutical Industry and Shanghai Pharmaceutical Group, and will establish Shanghai Shering-Plough Pharmaceutical as a wholly owned operation in Shanghai.
The buyout comes after a longstanding relationship with the companies, which Schering-Plough has been working with to dispense allergy and skincare products with since 1994.
- see the Schering-Plough release
- read the story at CNN Money
- see what Business Week says
- find the PharmaLive blog post
- get the latest at Forbes
Related Articles:
Chinese pharma leapfrogs ahead
Biotech entrepreneurs grow a new CRO in China
Big Pharma changes rules in emerging markets
China surges past India in drug discovery work
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
